Literature DB >> 8323854

Psychosocial correlates of AIDS-risk drug use and sexual behaviors.

D D Simpson1, K Knight, S Ray.   

Abstract

Theoretical and empirical research suggests psychosocial functioning is important in drug abuse intervention strategies, especially those focusing on efforts to change AIDS risk behaviors. Self-esteem, depression, anxiety, proneness to risk taking, decision-making confidence, self-assessment of drug use problems, and desire for help with drug problems, along with personal background and health history indicators, were assessed for 194 injection drug users in an AIDS prevention outreach program in New Orleans. Composite index scores for needle risk behaviors were associated with low self-esteem and low decision-making confidence as well as with higher scores on depression, anxiety, drug use problems, and desire for help. However, these psychosocial measures were not significantly related to the composite index for sex risks. Health history measures, represented by previous exposures to hepatitis and sexually transmitted diseases, were significantly related to both needle and sex risk indices. Implications for AIDS intervention efforts are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8323854

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  15 in total

1.  Impact of interim methadone maintenance on HIV risk behaviors.

Authors:  Monique E Wilson; Robert P Schwartz; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

2.  Gender Differences Among Prisoners With Pre-Incarceration Heroin Dependence Participating in a Randomized Clinical Trial of Buprenorphine Treatment.

Authors:  Michael S Gordon; Timothy W Kinlock; Kathryn A Couvillion; Monique E Wilson; Robert P Schwartz; Kevin E O'Grady
Journal:  J Offender Rehabil       Date:  2013-01-01

3.  Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.

Authors:  J S Atkinson; L Nilsson Schönnesson; M L Williams; S C Timpson
Journal:  AIDS Care       Date:  2008-02

4.  Sexual activity in HIV-positive African American crack cocaine smokers.

Authors:  Sandra C Timpson; Mark L Williams; Anne M Bowen; John S Atkinson; Michael W Ross
Journal:  Arch Sex Behav       Date:  2010-07-14

5.  Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

6.  Addiction severity index composite scores as predictors for sexual-risk behaviors and drug-use behaviors in drug-using pregnant patients.

Authors:  R Chaudhury; H E Jones; W Wechsberg; K E O'Grady; M Tuten; M S Chisolm
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

7.  HIV-related risk factors associated with commercial sex among female migrants in China.

Authors:  Hongmei Yang; Xiaoming Li; Bonita Stanton; Xinguang Chen; Hongjie Liu; Xiaoyi Fang; Danhua Lin; Rong Mao
Journal:  Health Care Women Int       Date:  2005-02

8.  Texas Christian University (TCU) Short Forms for Assessing Client Needs and Functioning in Addiction Treatment.

Authors:  D Dwayne Simpson; George W Joe; Kevin Knight; Grace A Rowan-Szal; Julie S Gray
Journal:  J Offender Rehabil       Date:  2012-03-07

9.  Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.

Authors:  Monique E Wilson; Timothy W Kinlock; Michael S Gordon; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2012 Sep-Oct

10.  A psychosocial comparison of New Orleans and Houston crack smokers in the wake of Hurricane Katrina.

Authors:  Sandra Timpson; Eric Ratliff; Michael Ross; Mark Williams; John Atkinson; Anne Bowen; Sheryl McCurdy
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.